Titan Pharmaceuticals, Inc.

Navigate Titan Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Who We Are
    • IP Portfolio
    • Management Team
    • Board of Directors
    • Careers
  • Technology
  • Pipeline
    • Kappa Opioid Receptor Agonist
    • Nalmefene Implant
  • News
    • Overview
    • Press Releases
    • Events
    • Presentations
    • In the News
    • Publications
    • Posters
    • Media Resources
  • Investors
    • Investor Relations
    • Overview
    • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Company Info
    • Company Information
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
    • Titan FCOI Policy
    • Stock Data
    • Quote
    • Charts
    • Historical Data
    • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact
  • Search

Press Releases

  • Home
  • Investors
  • News / Events
  • Press Releases
Investors

Navigate Investors

  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Press Releases

  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Titan Pharmaceuticals Provides Update on Confirmatory Phase 3 Study of Probuphine

June 30, 2011

Titan Pharmaceuticals to Present at 2011 BIO International Convention

June 27, 2011

Titan Pharmaceuticals Provides Additional Details on Confirmatory Phase 3 Study of Probuphine

June 17, 2011

Titan Pharmaceuticals Provides Update on Confirmatory Phase 3 Study of Probuphine

June 17, 2011

Titan Pharmaceuticals Announces First Quarter 2011 Financial Results

May 16, 2011

Titan Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results

March 24, 2011

Titan Pharmaceuticals Enters Into a $20 Million Credit Facility With Deerfield Management

March 16, 2011

Titan Reports Fourth Quarter 2010 Fanapt® Royalty

February 4, 2011

Titan Pharmaceuticals Presents Phase 3 Probuphineâ„¢ Data at Society for Neuroscience Annual Meeting

November 17, 2010

Titan Pharmaceuticals Announces Third Quarter 2010 Financial Results

November 15, 2010

RSS
  • « Previous
  • 1...
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • Next »
© 2022 Titan Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Titan FCOI Policy Disclaimer Sitemap